logo

GANX

Gain Therapeutics·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
3.63 / 10Overall Score
NeturalInvestment Rating
FundamentalSentimentTechnical
Trend Analysis of GANX
  • Based on a composite score of 3.63/10, we rate GANX as a Netural. Our analysis breaks down into 2.80/10 for Fundamentals, 2.35/10 for Technicals, and 4.69/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is GANX undervalued or overvalued?
Technical Analysis of GANX?
Is money flowing into or out of GANX?